Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Keljo

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
The American Journal of Surgical Pathology|September 2, 2017
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative ColitisBrendan Boyle, Margaret H Collins, Zhu Wang, et al.
Inflammatory Bowel Diseases|January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)Dan Turner, Jeffrey Hyams, James Markowitz, et al.
The American Journal of Gastroenterology|January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry studyJeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's DiseaseVictoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 1, 2012
Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitisBella Zeisler, Trudy Lerer, James Markowitz, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 11, 2020
Analysis of Using the Total White Blood Cell Count to Define Severe New-onset Ulcerative Colitis in ChildrenDavid R Mack, Bradley Saul, Brendan Boyle, et al.
The Journal of Pediatrics|May 19, 2015
Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American CohortMaria Oliva-Hemker, Susan Hutfless, Elie S Al Kazzi, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 11, 2010
Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severityJennifer L Dotson, Jeffrey S Hyams, James Markowitz, et al.
Cell Host & Microbe|October 12, 2018
Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease CourseMelanie Schirmer, Lee Denson, Hera Vlamakis, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
The American Journal of Surgical Pathology|September 2, 2017
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative ColitisBrendan Boyle, Margaret H Collins, Zhu Wang, et al.
Inflammatory Bowel Diseases|January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)Dan Turner, Jeffrey Hyams, James Markowitz, et al.
The American Journal of Gastroenterology|January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry studyJeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's DiseaseVictoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 1, 2012
Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitisBella Zeisler, Trudy Lerer, James Markowitz, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 11, 2020
Analysis of Using the Total White Blood Cell Count to Define Severe New-onset Ulcerative Colitis in ChildrenDavid R Mack, Bradley Saul, Brendan Boyle, et al.
The Journal of Pediatrics|May 19, 2015
Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American CohortMaria Oliva-Hemker, Susan Hutfless, Elie S Al Kazzi, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 11, 2010
Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severityJennifer L Dotson, Jeffrey S Hyams, James Markowitz, et al.
Cell Host & Microbe|October 12, 2018
Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease CourseMelanie Schirmer, Lee Denson, Hera Vlamakis, et al.
Pageof 4